Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

26.60
+0.06500.25%
Volume:208.97K
Turnover:5.51M
Market Cap:1.55B
PE:-3.82
High:26.63
Open:26.45
Low:26.04
Close:26.53
52wk High:46.00
52wk Low:22.24
Shares:58.31M
Float Shares:51.35M
Volume Ratio:0.62
T/O Rate:0.41%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.9625
EPS(LYR):11.64
ROE:-27.57%
ROA:-18.71%
PB:1.21
PE(LYR):2.28

Loading ...

Jan 12, 2026

Major Issues Report

Form 8-K - Current report
Jan 06, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 30, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Oct 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 30, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Sep 26, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 04, 2025

Major Issues Report

Form 8-K - Current report
Jul 31, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 31, 2025

Major Issues Report

Form 8-K - Current report